Clinical implications of genetic variation in the serotonin transporter promoter region: A review

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 11, Issue 3, 2009, Pages 93-102

  Luddington, Nicole S ^a   Mandadapu, Anitha ^a   Husk, Margaret ^a   El Mallakh, Rif S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77149149768     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.08r00656     Document Type: Article

References (100)

1. Vergne DE, Nemeroff CB. The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. Curr Psychiatry Rep 2006;8:452-457
2. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993;16:73-93
3. Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A 1993;90:2542-2546
4. Smith TD, Kuczenski R, George-Friedman K, et al. In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration. Synapse 2000; 38(4):460-470
5. Bundgaard C, Larsen F, Jørgensen M, et al. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels. Eur J Pharm Sci 2006;29(5):394-404
6. Lesch K P, Balling U, Gross J, et al. Organisation of the human serotonin transporter gene. J Neural Trans 1994;95:157-162
7. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66(6):2621-2624
8. Lesch K P, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531
9. Bradley SL, Dodelzon K, Sandhu HK, et al. Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Genet B Neuropsychiatr Genet 2005;136(1):58-61
10. Philibert RA, Sandhu H, Hollenbeck N, et al. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 2008; 147B(5):543-549
11. Greenberg BD, Tolliver TJ, Huang SJ, et al. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999;88(1):83-87
12. Kaiser R, Müller-Oerlinghausen B, Filler D, et al. Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphismand the 17-bp variable number tandem repeat of the serotonin transporter. Am J Med Genet 2002;114(3):323-328
13. Parsey RV, Hastings RS, Oquendo MA, et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 2006;163(1):48-51
14. Hranilovic D, Stefulj J, Schwab S, et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 2004;55(11):1090-1094
15. Bradley SL, Dodelzon K, Sandhu HK, et al. Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Genet B Neuropsychiatr Genet 2005;136B(1):58-61
16. Gelernter J, Cubells JF, Kidd JR, et al. Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 1999; 88(1):61-66
17. Lima L, Urbina M. Serotonin transporter modulation in blood lymphocytes from patients with major depression. Cell Mol Neurobiol 2002; 22(5-6):797-804
18. Must A, Juhász A, Rimanóczy A, et al. Major depressive disorder, serotonin transporter, and personality traits: why patients use suboptimal decision-making strategies? J Affect Disord 2007;103:273-276
19. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301:386-389
20. Wilhelm K, Mitchell PB, Niven H, et al. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 2006;188:210-215
21. Kendler KS, Kuhn JW, Vittum J, et al. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005; 62:529-535
22. Cervilla JA, Molina E, Rivera M, et al. The risk of depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort. Mol Psychiatry 2007;12:748-755
23. Kilpatrick DG, Koenen KC, Ruggiero KJ, et al. The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry 2007; 164:1693-1699
24. Kaufman J, Yang BZ, Douglas-Palumberi H, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 2004;101:17316-17321
25. Steiger H, Richardson J, Joober R, et al. The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes. J Psychiatry Neurosci 2007;32:354-362
26. Eley TC, Sugden K, Corsico A, et al. Gene environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004;9:908-915
27. Grabe HJ, Lange M, Wolff B, et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 2005;10(2): 220-224
28. Otte C, McCaffery J, Ali S, et al. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and nor-epinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry 2007;164:1379-1384
29. Jarrett ME, Kohen R, Cain KC, et al. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs 2007;9:161-169
30. Sojoberg RL, Nilsson KW, Nordquist N, et al. Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int J Neuropsychopharmacol 2005;9:1-7
31. Dorado P, Peñas-Lledó EM, González AP, et al. Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele. Fundam Clin Pharmacol 2007;21(4):451-453
32. Taylor SE, Baldwin M, Way BM, et al. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 2006;60:671-676
33. Gonda X, Juhasz G, Laszik A, et al. Subthreshold depression is linked to the functional polymorphism of the 5HT transporter gene. J Affect Disord 2005;87:291-297
34. Gonda X, Rihmer Z, Zsombok T, et al. The 5HTTLPR polymorphism of the serotonin transporter gene is associated with affective temperaments as measured by TEMPS-A. J Affect Disord 2006;91:125-131
35. Gillespie NA, Whitfield JB, Williams B, et al. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med 2005;25:101-111
36. Surtees PG, Wainwright NW, Willis-Owen SA, et al. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry 2006;59(3):224-229
37. Zammit S, Owen MJ. Stressful life events, 5-HTT genotype and risk of depression. Br J Psychiatry 2006;188:199-201
38. Micheli D, Bonvicini C, Rocchi A, et al. No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease. J Alzheimers Dis 2006;10(4):371-378
39. Chorbov VM, Lobos EA, Todorov AA, et al. Relationship of 5-HTTLPR genotypes and depression risk in the presence of trauma in a female twin sample. Am J Med Genet B Neuropsychiatr Genet 2007;144:830-833
40. Cervilla JA, Rivera M, Molina E, et al; PREDICT Study Core Group. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. Am J Med Genet B Neuropsychiatr Genet 2006;141(8):912-917
41. Zalsman G, Huang Y Y, Oquendo MA, et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 2006;163(9):1588-1593
42. Munafò MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 2008;63:852-857
43. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 2007;32(2): 86-102
44. Mandelli L, Serretti A, Marino E, et al. Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. Int J Neuropsychopharmacol 2007;10:437-447
45. Gerra G, Garofano L, Santoro G, et al. Association between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates. Am J Med Genet B Neuropsychiatr Genet 2004; 126B:37-42
46. Feinn R, Nellissery M, Kranzler HR. Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 2005;133B:79-84
47. Rujescu D, Giegling I, Sato T, et al. A polymorphism in the promoter of the serotonin transporter gene is not associated with suicidal behavior. Psychiatr Genet 2001;11:169-172
48. Baca-García E, Vaquero C, Diaz-Sastre C, et al. A gender-specific association between the serotonin transporter gene and suicide attempts. Neuropsychopharmacology 2002;26:692-695
49. Courtet P, Buresi C, Abbar M, et al. No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism. Am J Med Genet B Neuropsychiatr Genet 2003;116B:72-76
50. Baca-Garcia E, Vaquero C, Diaz-Sastre C, et al. Lack of association between the serotonin transporter promoter gene polymorphism and im-pulsivity or aggressive behavior among suicide attempters and healthy volunteers. Psychiatry Res 2004;126:99-106
51. Segal J, Pujol C, Birck A, et al. Association between suicide attempts in south Brazilian depressed patients with the serotonin transporter polymorphism. Psychiatry Res 2006;143:289-291
52. Helbecque N, Sparks DL, Hunsaker JC 3rd, et al. The serotonin transporter promoter polymorphism and suicide. Neurosci Lett 2006;400:13-15
53. Lopez de Lara C, Dumais A, Rouleau G, et al. STin2 variant and family history of suicide as significant predictors of suicide completion in major depression. Biol Psychiatry 2006;59:114-120
54. Pungercic G, Videtic A, Pestotnik A, et al. Serotonin transporter gene promoter (5-HTTLPR) and intron 2 (VNTR) polymorphisms: a study on Slovenian population of suicide victims. Psychiatr Genet 2006;16: 187-191
55. Preuss UW, Koller G, Soyka M, et al. Association between suicide attempts and 5-HTTLPR-S-allele in alcohol-dependent and control subjects: further evidence from a German alcohol-dependent inpatient sample. Biol Psychiatry 2001;50:636-639
56. Kronenberg S, Apter A, Brent D, et al. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. J Child Adolesc Psychopharmacol 2007;17(6):741-750
57. Bah J, Lindström M, Westberg L, et al. Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters. Psychiatry Res 2008;162:221-229
58. Neves FS, Silveira G, Romano-Silva MA, et al. Is the 5-HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients? Am J Med Genet B Neuropsychiatr Genet 2008;147B:114-116
59. Limosin F, Loze J Y, Boni C, et al. Male-specific association between the 5-HTTLPR S allele and suicide attempts in alcohol-dependent subjects. J Psychiatr Res 2005;39:179-182
60. Wasserman D, Geijer T, Sokolowski M, et al. Association of the serotonin transporter promoter polymorphism with suicide attempters with a high medical damage. Eur Neuropsychopharmacol 2007;17:230-233
61. Lin P Y, Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry 2004;55:1023-1030
62. Li D, He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry 2007;12:47-54
63. Courtet P, Picot MC, Bellivier F, et al. Serotonin transporter gene may be involved in short-term risk or subsequent suicide attempts. Biol Psychiatry 2004;55:46-51
64. Gibb BE, McGeary JE, Beevers CG, et al. Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. Suicide Life Threat Behav 2006;36:687-693
65. Roy A, Hu XZ, Janal MN, et al. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharma-cology 2007;32:2046-2052
66. Murphy GM, Hollander SB, Rodrigues HE, et al. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 2004;61:1163-1169
67. Pollock BG, Ferrell RE, Mulsant BH, et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacol 2000;23:587-590
68. Durham LK, Webb SM, Milos PM, et al. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology (Berl) 2004;174(4):525-529
69. Zanardi R, Benedetti F, Di Bella D, et al. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 2000;20:105-107
70. Zanardi R, Serretti A, Rossini D, et al. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry 2001;50:323-330
71. Yu YW, Tsai SJ, Chen TJ, et al. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002;7:1115-1119
72. Rausch JL, Johnson ME, Fell YJ, et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 2002;51:723-732
73. Smeraldi E, Zanardi R, Benedetti F, et al. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998;3(6):508-511
74. Kim DK, Lim S W, Lee S, et al. Serotonin transporter gene polymorphism and antidepressant response. NeuroReport 2000;11:215-219
75. Kang R-H, Wong M-L, Choi M-J, et al. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1317-1321
76. Kato M, Ikenaga Y, Wakeno M, et al. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism. Int Clin Psychopharmacol 2005;20:151-156
77. Kraft JB, Peters EJ, Slager SL, et al. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol Psychiatry 2007;61:734-742
78. Hu XZ, Rush AJ, Charney D, et al. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 2007; 64(7):783-792
79. Serretti A, Kato M, De Ronchi D, et al. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007;12:247-257
80. Serretti A, Cusin C, Rausch JL, et al. Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis. Psychiatry Res 2006; 145:61-65
81. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163(1):28-40
82. Mundo E, Walker M, Cate T, et al. The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings. Arch Gen Psychiatry 2001;58:539-544
83. Rousseva A, Henry C, van den Bulke D, et al. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J 2003;3(2):101-104
84. Masoliver E, Menoyo A, Perez V, et al. Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder. Psychiatr Genet 2006;16(1):25-29
85. Mansour HA, Talkowski ME, Wood J, et al. Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter. Ann Med 2005;37(8):590-602
86. Perlis RH, Mischoulon D, Smoller JW, et al. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry 2003;54:879-883
87. Popp J, Leucht S, Heres S, et al. Serotonin transporter polymorphisms and side effects in antidepressant therapy-a pilot study. Pharmacogenomics 2006;7:159-166
88. Smits K, Smits L, Peeters F, et al. Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 2007;22(3): 137-143
89. Reimherr FW, Adler LA, Amsterdam JD, et al. Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine. Presented at 46th annual meeting of the NCDEU; June 12-15, 2006; Boca Raton, Fla
90. Michelson D, Adler LA, Amsterdam JD, et al. Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. Presented at the 19th Congress of the European College of Neuropsychopharmacology (ECNP); Sept 16-20, 2006; Paris, France
91. Michelson D, Adler LA, Amsterdam JD, et al. Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2007;68(4): 582-587
92. Stamm TJ, Adli M, Kirchheiner J, et al. Serotonin transporter gene and response to lithium augmentation in depression. Psychiatr Genet 2008; 18:92-97
93. Smits KM, Smits LJ, Schouten JS, et al. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? a decision-analytic model. Clin Ther 2007;29(4):691-702
94. Rasmussen-Torvik LJ, McAlpine DD. Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils. Depress Anxiety 2007;24:350-357
95. Meyer JH, Wilson AA, Sagrati S, et al. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry 2004;161(5):826-835
96. Voineskos AN, Wilson AA, Boovariwala A, et al. Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography. Psychopharmacology (Berl) 2007;193(4):539-545
97. Souery D, Oswald P, Massat I, et al. Group for the Study of Resistant Depression. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry 2007;68(7):1062-1070
98. Solomon DA, Leon AC, Mueller TI, et al. Tachyphylaxis in unipolar major depressive disorder. J Clin Psychiatry 2005;66(3):283-290
99. Kukopulos A, Caliari B, Tundi A, et al. Rapid Cyclers, temperament, and antidepressants. Compr Psychiatry 1983;24(3):249-258
100. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152:1130-1138